- Report
- July 2025
- 155 Pages
Global
From €4283EUR$4,850USD£3,699GBP
- Report
- June 2025
- 101 Pages
Global
From €3047EUR$3,450USD£2,631GBP
- Report
- May 2025
- 191 Pages
Global
From €4371EUR$4,950USD£3,776GBP
- Report
- May 2025
- 102 Pages
Global
From €2605EUR$2,950USD£2,250GBP
- Report
- February 2026
- 100 Pages
Middle East, Africa
From €4238EUR$4,799USD£3,660GBP
- Report
- February 2026
- 180 Pages
Asia Pacific
From €6402EUR$7,250USD£5,530GBP
- Report
- February 2026
- 180 Pages
Europe
From €6402EUR$7,250USD£5,530GBP
- Report
- February 2026
- 180 Pages
North America
From €6402EUR$7,250USD£5,530GBP
- Report
- September 2025
- 80 Pages
Middle East
From €5254EUR$5,950USD£4,538GBP
- Report
- September 2025
- 125 Pages
Middle East
From €3753EUR$4,250USD£3,242GBP
- Report
- June 2025
- 100 Pages
United States
From €3091EUR$3,500USD£2,670GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3417EUR$3,869USD£2,951GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3417EUR$3,869USD£2,951GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3417EUR$3,869USD£2,951GBP
- Report
- July 2025
- 250 Pages
Europe
From €3417EUR$3,869USD£2,951GBP
- Report
- July 2025
- 250 Pages
North America
From €3417EUR$3,869USD£2,951GBP
- Report
- March 2026
- 139 Pages
United States
From €3531EUR$3,999USD£3,050GBP
- Report
- July 2025
- 250 Pages
North America
From €3417EUR$3,869USD£2,951GBP
- Report
- February 2026
- 108 Pages
Europe
From €5294EUR$5,995USD£4,573GBP
- Report
- February 2026
- 85 Pages
North America
From €5294EUR$5,995USD£4,573GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more